Tirzepatide, a GLP-1 receptor agonist and GIP receptor agonist, works by slowing gastric emptying and regulating appetiteeffects that build over the course of your week
The SURMOUNT-5 head-to-head trial demonstrated tirzepatide produces 47% more weight loss than semaglutide (20.2% vs 13.7%)
Speak with our doctors today to learn more about the benefits of GLP-1 agonists and whether they might be right for you
Injectable and oral forms Semaglutide can appear in more than one presentation
Exercise: Doing cardiovascular exercise and strength training can help in maintaining the weight
Severe abdominal pain, signs of pancreatitis (upper left pain radiating to the back), persistent vomiting lasting more than a few hours, severe dehydration with dizziness upon standing, or rapid heartbeat should prompt a call to your prescribing provider or emergency care